SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
SANUWAVE Health (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, announced it will host a conference call on November 8, 2024, at 8:30 AM (ET) to discuss its Q3 2024 financial results. Participants can join via toll-free number 1-800-267-6316 or international number 1-203-518-9783 using Conference ID: SANUWAVE. Materials will be available on the company's website, and a replay will be accessible through November 29, 2024, using replay access ID: 11157276.
SANUWAVE Health (OTCQB: SNWV), un fornitore leader di prodotti per la cura delle ferite di nuova generazione approvati dalla FDA, ha annunciato che terrà una teleconferenza il 8 novembre 2024, alle 8:30 AM (ET) per discutere i risultati finanziari del terzo trimestre 2024. I partecipanti possono unirsi tramite il numero verde 1-800-267-6316 o il numero internazionale 1-203-518-9783 utilizzando l'ID della conferenza: SANUWAVE. I materiali saranno disponibili sul sito web dell'azienda e una registrazione sarà accessibile fino al 29 novembre 2024, utilizzando l'ID di accesso alla registrazione: 11157276.
SANUWAVE Health (OTCQB: SNWV), un proveedor líder de productos de cuidado de heridas de próxima generación aprobados por la FDA, anunció que llevará a cabo una conferencia telefónica el 8 de noviembre de 2024, a las 8:30 AM (ET) para discutir sus resultados financieros del tercer trimestre de 2024. Los participantes pueden unirse a través del número gratuito 1-800-267-6316 o del número internacional 1-203-518-9783 usando el ID de Conferencia: SANUWAVE. Los materiales estarán disponibles en el sitio web de la empresa y se podrá acceder a una repetición hasta el 29 de noviembre de 2024, utilizando el ID de acceso a la repetición: 11157276.
SANUWAVE Health (OTCQB: SNWV)는 FDA 승인을 받은 차세대 상처 치료 제품의 선도적인 공급업체로, 2024년 11월 8일 오전 8시 30분(ET)에 2024년 제3분기 재무 결과에 대한 컨퍼런스 콜을 개최한다고 발표했습니다. 참가자는 무료 전화번호 1-800-267-6316 또는 국제 전화번호 1-203-518-9783을 사용하여 SANUWAVE라는 컨퍼런스 ID로 참여할 수 있습니다. 자료는 회사 웹사이트에서 확인할 수 있으며, 2024년 11월 29일까지 반복 재생이 가능하고, 재생 접근 ID는 11157276입니다.
SANUWAVE Health (OTCQB: SNWV), un fournisseur leader de produits de soins des plaies de nouvelle génération approuvés par la FDA, a annoncé qu'il tiendrait une conférence téléphonique le 8 novembre 2024 à 8h30 (ET) pour discuter de ses résultats financiers du troisième trimestre 2024. Les participants peuvent rejoindre via le numéro sans frais 1-800-267-6316 ou le numéro international 1-203-518-9783 en utilisant l'ID de conférence : SANUWAVE. Les documents seront disponibles sur le site Web de l'entreprise, et un enregistrement sera accessible jusqu'au 29 novembre 2024, en utilisant l'ID d'accès à l'enregistrement : 11157276.
SANUWAVE Health (OTCQB: SNWV), ein führender Anbieter von FDA-zugelassenen Wundversorgungsprodukten der nächsten Generation, gab bekannt, dass am 8. November 2024 um 8:30 Uhr (ET) eine Telefonkonferenz stattfinden wird, um die Finanzergebnisse des dritten Quartals 2024 zu besprechen. Teilnehmer können sich über die gebührenfreie Nummer 1-800-267-6316 oder die internationale Nummer 1-203-518-9783 mit der Konferenz-ID: SANUWAVE einwählen. Materialien werden auf der Website des Unternehmens verfügbar sein, und eine Wiederholung wird bis zum 29. November 2024 zugänglich sein, mit der Wiederholungszugangs-ID: 11157276.
- None.
- None.
EDEN PRAIRIE, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, November 8, 2024, at 8:30 AM (ET) to present its Q3 2024 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-267-6316
Toll/International: 1-203-518-9783
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event:
https://viavid.webcasts.com/starthere.jsp?ei=1692398&tp_key=e3cff43c54
Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.
A replay will be made available through November 29, 2024:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11157276
About SANUWAVE
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with supply chain and production constraints, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
investors@sanuwave.com
FAQ
When will SANUWAVE Health (SNWV) report Q3 2024 earnings?
How can investors access SANUWAVE's (SNWV) Q3 2024 earnings call?
Until when will SANUWAVE's (SNWV) Q3 2024 earnings call replay be available?
